AstraZeneca PLC - Price To Sales Ratio

AstraZeneca PLC's Fiscal Year is From January To December.

The item "Price-To-Sales-Ratio" stands at 3.96 as of 09/30/2025.

As of the end of AstraZeneca PLC's third quarter, the item "Price To Sales Ratio" stands at 3.96. This represents an increase of 2.72 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -14.40 percent compared to the value the year prior.
The 1 year change in percent is -14.40.
The 3 year change in percent is 8.00.

The Serie's long term average value is 4.36. It's latest available value, on 09/30/2025, is 9.08 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2022, to it's latest available value, on 09/30/2025, is +8.00%.
The Serie's change in percent from it's maximum value, on 06/30/2024, to it's latest available value, on 09/30/2025, is -18.80%.